Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese HSK 1 – For Medical Students & Physicians A complete 20-lesson, 300-page Chinese HSK 1 course with a companion app in 21 languages — free forever. Arabic, Bengali, Dutch, English, Farsi, French, German, Hindi, Indonesian, Italian, Japanese, Korean, Portuguese, Russian, Spanish, Tagalog, Thai, Turkish, Ukrainian, Urdu, Vietnamese. By Bernd Sebastian Kamps and Andrea Melis

Nuclear Medicine

Free Subscription Articles published in Brain Retrieve available abstracts of 59 articles: HTML format

Single Articles

April 2026
1. COOMANS EM, Smith R, Pawlik D, Oliveira Hauer K, et al
   Neuropathological correlates of age and sex differences in 18F-flortaucipir PET.
   Brain. 2026 Apr 20:awag136. doi: 10.1093.
   PubMed     Abstract available
   
   
   
2. BENINA N, Buitrago L, De Simone FI, Radwan RR, et al
   Plasma pTau 217/beta-amyloid 1-42 ratio for enhanced accuracy and reduced uncertainty in detecting amyloid pathology.
   Brain. 2026;149:1168-1181.
   PubMed     Abstract available
   
   
   
3. MANASOVA D, Belloli LML, Rosenfelder MJ, Willacker L, et al
   Multimodal multicentre investigation of diagnostic and prognostic markers in disorders of consciousness.
   Brain. 2026;149:1381-1395.
   PubMed     Abstract available
   
   
   February 2026
4. COGSWELL PM, Lundt ES, Therneau TM, Hu M, et al
   Modelling the temporal evolution of plasma p-tau217, amyloid PET, tau PET and cognition.
   Brain. 2026 Feb 25:awag075. doi: 10.1093.
   PubMed     Abstract available
   
   
   
5. MIZUNO Y, Carreira Figueiredo I, Pillinger T, Hindley G, et al
   Immune alterations in schizophrenia and the effects of a therapeutic antibody: a neuroimaging study.
   Brain. 2026;149:620-631.
   PubMed     Abstract available
   
   
   
6. CHIARO G, Vichayanrat E, Koay S, Rogeau A, et al
   Pure autonomic failure: a natural history study of the Queen Square cohort.
   Brain. 2026;149:606-619.
   PubMed     Abstract available
   
   
   January 2026
7. KALINOWSKI A, Steinman L
   The complexity of interpreting TSPO PET neuroimaging in first-episode psychosis.
   Brain. 2026 Jan 8:awaf476. doi: 10.1093.
   PubMed    
   
   
   December 2025
8. ZHU GH, He R, Yang ZY, Wang TT, et al
   Compensatory roles of STT3A and ALG5 in glucose metabolism of aged macaque hippocampus.
   Brain. 2025;148:4416-4434.
   PubMed     Abstract available
   
   
   
9. HVINGELBY VS, Terkelsen MH, Johnsen EL, Moller M, et al
   Cholinergic patterns correlate with dopamine medication ON freezing of gait in Parkinson's disease.
   Brain. 2025;148:4508-4518.
   PubMed     Abstract available
   
   
   November 2025
10. KIM R, Jin B, Kim H, Woo KA, et al
    Cholinergic basal forebrain degeneration in isolated REM sleep behaviour disorder.
    Brain. 2025;148:4084-4097.
    PubMed     Abstract available
    
    
    October 2025
11. ALBORNOZ EA, Mardon K, Bhalla R, Kumar V, et al
    PET-MRI biomarkers reveal efficacy of a novel NLRP3 inhibitor in Parkinson's disease models.
    Brain. 2025 Oct 16:awaf372. doi: 10.1093.
    PubMed     Abstract available
    
    
    
12. KARLSSON L, Janelidze S, Barthelemy NR, Horie K, et al
    Reference proteins to improve Core 1 and Core 2 Alzheimer's disease CSF and plasma biomarkers.
    Brain. 2025 Oct 6:awaf375. doi: 10.1093.
    PubMed     Abstract available
    
    
    September 2025
13. JOHNSON DR, Wiste HJ, Lowe V, Schwarz CG, et al
    Staging Alzheimer's disease through amyloid and tau PET.
    Brain. 2025 Sep 19:awaf346. doi: 10.1093.
    PubMed     Abstract available
    
    
    
14. PESCOLLER J, Dewenter A, Dehsarvi A, Steward A, et al
    Cortical tau deposition promotes atrophy in connected white matter regions in Alzheimer's disease.
    Brain. 2025 Sep 12:awaf339. doi: 10.1093.
    PubMed     Abstract available
    
    
    August 2025
15. DE BRUIN H, Groot C, Barthel H, Bischof GN, et al
    Connectivity as a universal predictor of tau progression in atypical Alzheimer's disease.
    Brain. 2025 Aug 14:awaf279. doi: 10.1093.
    PubMed     Abstract available
    
    
    July 2025
16. ANAND C, Abdelnour F, Sipes B, Ma D, et al
    Selective vulnerability and resilience to Alzheimer's disease tauopathy as a function of genes and the connectome.
    Brain. 2025 Jul 9:awaf179. doi: 10.1093.
    PubMed     Abstract available
    
    
    
17. KAZAZIAN K, Monti MM, Owen AM
    Functional neuroimaging in disorders of consciousness: towards clinical implementation.
    Brain. 2025;148:2283-2298.
    PubMed     Abstract available
    
    
    
18. SILVA-RODRIGUEZ J, Labrador-Espinosa MA, Zhang L, Castro-Labrador S, et al
    The effect of Lewy body (co-)pathology on the clinical and imaging phenotype of amnestic patients.
    Brain. 2025;148:2441-2452.
    PubMed     Abstract available
    
    
    
19. CICOGNOLA C, Salvado G, Smith R, Palmqvist S, et al
    APOE4 impact on soluble and insoluble tau pathology is mostly influenced by amyloid-beta.
    Brain. 2025;148:2373-2383.
    PubMed     Abstract available
    
    
    June 2025
20. PRANGE S, Metereau E, Klinger H, Huddlestone M, et al
    Serotonergic dysfunction in patients with impulse control disorders in Parkinson's disease.
    Brain. 2025;148:2108-2121.
    PubMed     Abstract available
    
    
    May 2025
21. KOCH PJ, Frey BM, Backhaus W, Petersen N, et al
    Neurotransmitter-informed connectivity maps and their application for outcome inference after stroke.
    Brain. 2025 May 20:awaf185. doi: 10.1093.
    PubMed     Abstract available
    
    
    
22. HONG H, Tozer DJ, Chen Y, Brown RB, et al
    Perivascular space dysfunction in cerebral small vessel disease is related to neuroinflammation.
    Brain. 2025;148:1540-1550.
    PubMed     Abstract available
    
    
    April 2025
23. LU K, Baker J, Nicholas JM, Street RE, et al
    Associations between accelerated forgetting, amyloid deposition and brain atrophy in older adults.
    Brain. 2025;148:1302-1315.
    PubMed     Abstract available
    
    
    February 2025
24. WIJESINGHE SS, Rowe JB, Mason HD, Allinson KSJ, et al
    Post-mortem validation of in vivo TSPO PET as a microglial biomarker.
    Brain. 2025 Feb 26:awaf078. doi: 10.1093.
    PubMed     Abstract available
    
    
    
25. EIFF B, Bullmore ET, Clatworthy MR, Fryer TD, et al
    Extra-axial inflammatory signal and its relationship to peripheral and central immunity in depression.
    Brain. 2025;148:635-646.
    PubMed     Abstract available
    
    
    
26. WARMENHOVEN N, Salvado G, Janelidze S, Mattsson-Carlgren N, et al
    A comprehensive head-to-head comparison of key plasma phosphorylated tau 217 biomarker tests.
    Brain. 2025;148:416-431.
    PubMed     Abstract available
    
    
    
27. MALPETTI M, Swann P, Tsvetanov KA, Chouliaras L, et al
    Blood inflammation relates to neuroinflammation and survival in frontotemporal lobar degeneration.
    Brain. 2025;148:493-505.
    PubMed     Abstract available
    
    
    January 2025
28. FERNANDEZ ARIAS J, Brum WS, Salvado G, Therriault J, et al
    Plasma phosphorylated tau217 strongly associates with memory deficits in the Alzheimer's disease spectrum.
    Brain. 2025 Jan 29:awaf033. doi: 10.1093.
    PubMed     Abstract available
    
    
    
29. TOHYAMA S, Datko M, Brusaferri L, Kinder LD, et al
    Trigeminal nerve microstructure is linked with neuroinflammation and brainstem activity in migraine.
    Brain. 2025 Jan 28:awaf029. doi: 10.1093.
    PubMed     Abstract available
    
    
    
30. SAINBURG LE, Englot DJ, Morgan VL
    The impact of resective epilepsy surgery on the brain network: evidence from post-surgical imaging.
    Brain. 2025 Jan 24:awaf026. doi: 10.1093.
    PubMed     Abstract available
    
    
    
31. CHAUVEAU L, Landeau B, Dautricourt S, Turpin AL, et al
    Anterior-temporal network hyperconnectivity is key to Alzheimer's disease: from ageing to dementia.
    Brain. 2025 Jan 15:awaf008. doi: 10.1093.
    PubMed     Abstract available
    
    
    
32. WIMBERLEY C, Thompson G
    Bridging peripheral and central inflammation with TSPO-PET: insights into depression and beyond.
    Brain. 2025 Jan 9:awae403. doi: 10.1093.
    PubMed    
    
    
    November 2024
33. DUONG MT, Das SR, Khandelwal P, Lyu X, et al
    Hypometabolic mismatch with atrophy and tau pathology in mixed Alzheimer and Lewy body disease.
    Brain. 2024 Nov 22:awae352. doi: 10.1093.
    PubMed     Abstract available
    
    
    
34. SAKATO Y, Shima A, Terada Y, Takeda K, et al
    Delineating three distinct spatiotemporal patterns of brain atrophy in Parkinson's disease.
    Brain. 2024;147:3702-3713.
    PubMed     Abstract available
    
    
    
35. SPITZ G, Hicks AJ, McDonald SJ, Dore V, et al
    Plasma biomarkers in chronic single moderate-severe traumatic brain injury.
    Brain. 2024;147:3690-3701.
    PubMed     Abstract available
    
    
    October 2024
36. KATSUMI Y, Howe IA, Eckbo R, Wong B, et al
    Default mode network tau predicts future clinical decline in atypical early Alzheimer's disease.
    Brain. 2024 Oct 16:awae327. doi: 10.1093.
    PubMed     Abstract available
    
    
    
37. BANWINKLER M, Dzialas V, Rigoux L, Asendorf AL, et al
    Putaminal dopamine modulates movement motivation in Parkinson's disease.
    Brain. 2024;147:3352-3357.
    PubMed     Abstract available
    
    
    
38. D'ANGREMONT E, van der Zee S, Slingerland S, Slomp AC, et al
    Cholinergic deficiency in Parkinson's disease patients with visual hallucinations.
    Brain. 2024;147:3370-3378.
    PubMed     Abstract available
    
    
    September 2024
39. ABANTO J, Dwivedi AK, Imbimbo BP, Espay AJ, et al
    Increases in amyloid-beta42 slow cognitive and clinical decline in Alzheimer's disease trials.
    Brain. 2024 Sep 11:awae216. doi: 10.1093.
    PubMed     Abstract available
    
    
    July 2024
40. APPLETON J, Finn Q, Zanotti-Fregonara P, Yu M, et al
    Brain inflammation co-localizes highly with tau in mild cognitive impairment due to early-onset Alzheimer's disease.
    Brain. 2024 Jul 16:awae234. doi: 10.1093.
    PubMed     Abstract available
    
    
    
41. DEVULDER A, Vanderlinden G, Van Langenhoven L, Testelmans D, et al
    Epileptic activity on foramen ovale electrodes is associated with sleep and tau pathology in Alzheimer's disease.
    Brain. 2024 Jul 11:awae231. doi: 10.1093.
    PubMed     Abstract available
    
    
    
42. NILSSON J, Pichet Binette A, Palmqvist S, Brum WS, et al
    Cerebrospinal fluid biomarker panel for synaptic dysfunction in a broad spectrum of neurodegenerative diseases.
    Brain. 2024;147:2414-2427.
    PubMed     Abstract available
    
    
    June 2024
43. PERETTI DE, Boccalini C, Ribaldi F, Scheffler M, et al
    Association of glial fibrillary acid protein, Alzheimer's disease pathology and cognitive decline.
    Brain. 2024 Jun 28:awae211. doi: 10.1093.
    PubMed     Abstract available
    
    
    
44. ROEMER SN, Brendel M, Gnoerich J, Malpetti M, et al
    Subcortical tau is linked to hypoperfusion in connected cortical regions in 4-repeat tauopathies.
    Brain. 2024 Jun 6:awae174. doi: 10.1093.
    PubMed     Abstract available
    
    
    May 2024
45. ALTMANN A, Aksman LM, Oxtoby NP, Young A, et al
    Towards cascading genetic risk in Alzheimer's disease.
    Brain. 2024 May 31:awae176. doi: 10.1093.
    PubMed     Abstract available
    
    
    
46. TETZLOFF KA, Martin PR, Duffy JR, Utianski RL, et al
    Longitudinal flortaucipir, metabolism and volume differ between phonetic and prosodic speech apraxia.
    Brain. 2024;147:1696-1709.
    PubMed     Abstract available
    
    
    
47. CROWLEY SJ, Kanel P, Roytman S, Bohnen NI, et al
    Basal forebrain integrity, cholinergic innervation and cognition in idiopathic Parkinson's disease.
    Brain. 2024;147:1799-1808.
    PubMed     Abstract available
    
    
    April 2024
48. CODY KA, Langhough RE, Zammit MD, Clark L, et al
    Characterizing brain tau and cognitive decline along the amyloid timeline in Alzheimer's disease.
    Brain. 2024 Apr 26:awae116. doi: 10.1093.
    PubMed     Abstract available
    
    
    
49. WANG YT, Therriault J, Servaes S, Tissot C, et al
    Sex-specific modulation of amyloid-beta on tau phosphorylation underlies faster tangle accumulation in females.
    Brain. 2024;147:1497-1510.
    PubMed     Abstract available
    
    
    March 2024
50. DE MEYER S, Blujdea ER, Schaeverbeke J, Reinartz M, et al
    Longitudinal associations of serum biomarkers with early cognitive, amyloid and grey matter changes.
    Brain. 2024;147:936-948.
    PubMed     Abstract available
    
    
    February 2024
51. YANG HS, Yau WW, Carlyle BC, Trombetta BA, et al
    Plasma VEGFA and PGF impact longitudinal tau and cognition in preclinical Alzheimer's disease.
    Brain. 2024 Feb 5:awae034. doi: 10.1093.
    PubMed     Abstract available
    
    
    January 2024
52. HERRANZ E, Treaba CA, Barletta VT, Mehndiratta A, et al
    Characterization of cortico-meningeal translocator protein expression in multiple sclerosis.
    Brain. 2024 Jan 30:awae030. doi: 10.1093.
    PubMed     Abstract available
    
    
    
53. BAGNATO F, Sati P, Hemond CC, Elliott C, et al
    Imaging chronic active lesions in multiple sclerosis: a consensus statement.
    Brain. 2024 Jan 16:awae013. doi: 10.1093.
    PubMed     Abstract available
    
    
    December 2023
54. SCHUMACHER J, Kanel P, Dyrba M, Storch A, et al
    Structural and molecular cholinergic imaging markers of cognitive decline in Parkinson's disease.
    Brain. 2023;146:4964-4973.
    PubMed     Abstract available
    
    
    November 2023
55. SILVA-RODRIGUEZ J, Labrador-Espinosa MA, Moscoso A, Scholl M, et al
    Characteristics of amnestic patients with hypometabolism patterns suggestive of Lewy body pathology.
    Brain. 2023;146:4520-4531.
    PubMed     Abstract available
    
    
    October 2023
56. LAURENCIN C, Lancelot S, Brosse S, Merida I, et al
    Noradrenergic alterations in Parkinson's disease: a combined 11C-yohimbine PET/neuromelanin MRI study.
    Brain. 2023 Oct 3:awad338. doi: 10.1093.
    PubMed     Abstract available
    
    
    September 2023
57. BOCANCEA DI, Svenningsson AL, van Loenhoud AC, Groot C, et al
    Determinants of cognitive and brain resilience to tau pathology: a longitudinal analysis.
    Brain. 2023;146:3719-3734.
    PubMed     Abstract available
    
    
    
58. COOMANS EM, Tomassen J, Ossenkoppele R, Tijms BM, et al
    Genetically identical twin-pair difference models support the amyloid cascade hypothesis.
    Brain. 2023;146:3735-3746.
    PubMed     Abstract available
    
    
    July 2023
59. AKSMAN LM, Oxtoby NP, Scelsi MA, Wijeratne PA, et al
    A data-driven study of Alzheimer's disease related amyloid and tau pathology progression.
    Brain. 2023 Jul 11:awad232. doi: 10.1093.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Nuclear Medicine is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum